# OnCo record the-0504 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/the-0504/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "the-0504" ;
  schema:name "THE-0504"@en ;
  schema:description "THE-0504 is an experimental human ferritin nanocage drug carrier loaded with a topoisomerase I inhibitor from Thena Biotech, in phase 1 trials for small cell lung cancer, colorectal carcinoma and pancreatic adenocarcinoma and other cancers."@en ;
  schema:url <https://onco.cc/drugs/the-0504/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://thenabiotech.com/>, <https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC7877078&resultType=core&format=json>, <https://clinicaltrials.gov/api/v2/studies/NCT07646106>, <https://clinicaltrials.gov/search?intr=THE-0504> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Human ferritin (HFt) nanocage drug carrier loaded with a topoisomerase I inhibitor" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/tfrc/> ;
  onco:companies <https://onco.cc/companies/thena-biotech/> ;
  onco:trials <https://onco.cc/trials/nct07646106/> .